Literature DB >> 26251941

Length of Stay and Readmission After Total Shoulder Arthroplasty: An Analysis of 1505 Cases.

Bryce A Basques, Elizabeth C Gardner, Jason O Toy, Nicholas S Golinvaux, Daniel D Bohl, Jonathan N Grauer1.   

Abstract

We conducted a study to characterize the risk factors for extended length of stay (LOS) and readmission after primary total shoulder arthroplasty (TSA). Patients who were 60 years or older and underwent TSA between 2011 and 2012 were identified from the American College of Surgeons National Surgical Quality Improvement Program database. Bivariate and multivariate analyses were used to test patient characteristics for association with extended LOS and readmission within 30 days. Extended LOS was defined as LOS of more than 3 days (90th percentile LOS). Of the 1505 TSA patients identified, 49 (3.3%) were readmitted. Multivariate analysis revealed that extended LOS was independently associated with age 70 years or older and history of diabetes. Readmission was independently associated with history of heart disease and history of hypertension. The identified risk factors may be useful for preoperative discussions, surgical decision-making, and postoperative planning for THA patients.

Entities:  

Mesh:

Year:  2015        PMID: 26251941

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  10 in total

1.  Diabetes Disease Severity Was Not Associated with Risk of Deep Infection or Revision After Shoulder Arthroplasty.

Authors:  Matthew D McElvany; Priscilla H Chan; Heather A Prentice; Elizabeth W Paxton; Mark T Dillon; Ronald A Navarro
Journal:  Clin Orthop Relat Res       Date:  2019-06       Impact factor: 4.176

2.  Perioperative Risk Adjustment for Total Shoulder Arthroplasty: Are Simple Clinically Driven Models Sufficient?

Authors:  David N Bernstein; Aakash Keswani; David Ring
Journal:  Clin Orthop Relat Res       Date:  2017-12       Impact factor: 4.176

3.  Trends in operative duration of total shoulder arthroplasty from 2008 to 2018: a national database study.

Authors:  Edward J Testa; Nicholas J Lemme; Lambert T Li; Steven DeFroda
Journal:  Shoulder Elbow       Date:  2021-04-24

4.  Analysis of patient's willingness and concerns for discharge following shoulder arthroplasty.

Authors:  Kevin M Magone; Erel Ben-Ari; Dan Gordan; Yaniv Pines; Michael A Boin; Young W Kwon; Joseph D Zuckerman; Mandeep S Virk
Journal:  JSES Int       Date:  2022-02-03

5.  Is Hepatitis C Infection Associated With a Higher Risk of Complications After Total Shoulder Arthroplasty?

Authors:  Jourdan M Cancienne; Ian J Dempsey; Russell E Holzgrefe; Stephen F Brockmeier; Brian C Werner
Journal:  Clin Orthop Relat Res       Date:  2016-07-22       Impact factor: 4.176

6.  Perioperative Factors Affecting the Length of Hospitalization After Shoulder Arthroplasty.

Authors:  Joseph J King; Matthew R Patrick; Aimee M Struk; Ryan E Schnetzer; Kevin W Farmer; Cynthia Garvan; Thomas W Wright
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2017-10-09

7.  Delayed hospital discharge after total shoulder arthroplasty: why, and who is at risk?

Authors:  Mariano E Menendez; Sarah M Lawler; Michael P Carducci; David Ring; Kuhan A Mahendraraj; Andrew Jawa
Journal:  JSES Open Access       Date:  2019-09-17

8.  Short-Term Complications and Readmission Following Total Shoulder Arthroplasty: A National Database Study.

Authors:  Henry M Fox; Matthew J Best; Jacob D Mikula; Keith T Aziz; Uma Srikumaran
Journal:  Arch Bone Jt Surg       Date:  2021-05

9.  Ambulatory versus inpatient shoulder arthroplasty: a population-based analysis of trends, outcomes, and charges.

Authors:  Gabriella E Ode; Susan Odum; Patrick M Connor; Nady Hamid
Journal:  JSES Int       Date:  2020-01-03

10.  Trends in total shoulder arthroplasty from 2005 to 2018: lower complications rates and shorter lengths of stay despite patients with more comorbidities.

Authors:  Elise C Bixby; Venkat Boddapati; Matthew J J Anderson; John D Mueller; Charles M Jobin; William N Levine
Journal:  JSES Int       Date:  2020-06-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.